- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04273308
The Effect of Whole-body Vibration Training
February 17, 2020 updated by: HUI CHUN YANG, National Taipei University of Nursing and Health Sciences
The Effect of Whole-body Vibration Training on Biomarkers and Health Beliefs of Prefrail Older Adults: A Quasi-experimental Research
The whole-body vibration programme employed in this study partly improved the biomarkers and health beliefs of the prefrail community-dwelling older adults.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The experimental group participated in a 12-week whole-body vibration training that conducted 3 times per week, with 5-min continuous vibration at 12-Hz frequency and 3-mm amplitude each time
Study Type
Interventional
Enrollment (Actual)
42
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
65 years to 99 years (Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age of 65 years or older and living in a community
- Full consciousness and able to communicate verbally
- No severe cognitive disorder
Exclusion Criteria:
- Impaired mobility after recent surgery
- Major illness such as cancer
- Severe hearing impairment and inability to fully understand and follow instructions
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: whole-body vibration training
a 12-week whole-body vibration training that conducted 3 times per week, with 5-min continuous vibration at 12-Hz frequency and 3-mm amplitude each time.
|
The experimental group participated in a 12-week whole-body vibration training that was conducted 3 times per week, with 5-min continuous vibration at 12-Hz frequency and 3-mm amplitude each time.
The control group were provided home DVDs on resistance exercise and manuals for preventing frailty
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pretest and posttest results of the experimental and control groups for Grip strength
Time Frame: Change from baseline at 12 weeks (The experimental group participated training that was conducted 3 times per week, with 5-min continuous vibration)
|
Comparison of grip strength before and after 12 weeks of training
|
Change from baseline at 12 weeks (The experimental group participated training that was conducted 3 times per week, with 5-min continuous vibration)
|
Pretest and posttest results of the experimental and control groups for 15-foot walk test speed
Time Frame: Change from baseline at 12 weeks (The experimental group participated training that was conducted 3 times per week, with 5-min continuous vibration)
|
Comparison of 15-foot walk test speed before and after 12 weeks of training
|
Change from baseline at 12 weeks (The experimental group participated training that was conducted 3 times per week, with 5-min continuous vibration)
|
Pretest and posttest results of the experimental and control groups for One-leg standing test using the dominant leg with the eyes open
Time Frame: Change from baseline at 12 weeks (The experimental group participated training that was conducted 3 times per week, with 5-min continuous vibration)
|
Comparison of One-leg standing test with the eyes open before and after 12 weeks of training
|
Change from baseline at 12 weeks (The experimental group participated training that was conducted 3 times per week, with 5-min continuous vibration)
|
Pretest and posttest results of the experimental and control groups for Thirty-second chair stand test
Time Frame: Change from baseline at 12 weeks (The experimental group participated training that was conducted 3 times per week, with 5-min continuous vibration)
|
Comparison of Thirty-second chair stand test before and after 12 weeks of training
|
Change from baseline at 12 weeks (The experimental group participated training that was conducted 3 times per week, with 5-min continuous vibration)
|
Pretest and posttest results of the experimental and control groups for Two-minute step test
Time Frame: Change from baseline at 12 weeks (The experimental group participated training that was conducted 3 times per week, with 5-min continuous vibration)
|
Comparison of Two-minute step test before and after 12 weeks of training
|
Change from baseline at 12 weeks (The experimental group participated training that was conducted 3 times per week, with 5-min continuous vibration)
|
Pretest and posttest results of the experimental and control groups for Health beliefs
Time Frame: The twelfth week
|
Comparison of health beliefs before and after 12 weeks
|
The twelfth week
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Summary of posttest ANCOVA of the experimental and control groups for biomarkers
Time Frame: The twelfth week
|
One-way ANCOVA was conducted using the groups as the independent variable and the pretest results and sex as covariate variables to assess the intervention effectiveness
|
The twelfth week
|
Summary of posttest ANCOVA of the experimental and control groups for health beliefs
Time Frame: The twelfth week
|
One-way ANCOVA was conducted using the groups as the independent variable and the pretest results and sex as covariate variables to assess the intervention effectiveness
|
The twelfth week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 18, 2016
Primary Completion (Actual)
June 25, 2016
Study Completion (Actual)
June 25, 2016
Study Registration Dates
First Submitted
November 6, 2019
First Submitted That Met QC Criteria
February 17, 2020
First Posted (Actual)
February 18, 2020
Study Record Updates
Last Update Posted (Actual)
February 18, 2020
Last Update Submitted That Met QC Criteria
February 17, 2020
Last Verified
February 1, 2020
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 201510ES014
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Biomarkers
-
Peking UniversityCompleted
-
University of MinnesotaCompleted
-
University of California, DavisUSDA, Western Human Nutrition Research CenterRecruiting
-
Harvard School of Public Health (HSPH)CompletedBiomarkersUnited States
-
West China HospitalRecruitingBiomarkers | NeonateChina
-
U.S. Army Medical Research and Development CommandWalter Reed Army Institute of Research (WRAIR)CompletedBiomarkers, PharmacologicalUnited States
-
Five Liters, Inc.Northwell Health; The Feinstein Institutes for Medical ResearchRecruitingHemostasis | Blood BiomarkersUnited States
-
CareDxRecruitingLiver Transplantation | BiomarkersUnited States
-
Washington State UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedInteraction | Endogenous BiomarkersUnited States
-
Claudine MANACHNational Research Agency, FranceCompletedBiomarkers | Food IntakeFrance
Clinical Trials on whole-body vibration training
-
Schön Klinik Berchtesgadener LandCompletedChronic Obstructive Pulmonary DiseaseGermany
-
Florida State UniversityNutrisystem, Inc.CompletedHypertension | Obesity | Pre-hypertensionUnited States
-
Georgia State UniversityTerminatedFalls PreventionUnited States
-
Istanbul UniversityUnknownIdiopathic Pulmonary Fibrosis | Interstitial Lung Disease | SclerodermaTurkey
-
University Hospital, Basel, SwitzerlandCompletedItch; AthleteSwitzerland
-
Schön Klinik Berchtesgadener LandCompletedChronic Obstructive Pulmonary DiseaseGermany
-
Universidade Federal de PernambucoUnknownRenal Transplant RecipientsBrazil
-
University of BaselUniversity Hospital, Basel, Switzerland; University Hospital of Cologne; German... and other collaboratorsUnknownChemotherapy-induced Peripheral NeuropathySwitzerland
-
Okan UniversityBitlis Eren UniversityCompletedMuscle Strength | Vibration; Exposure | Lower LimbTurkey